Document is current
Any future updates will be listed below
-
Authors
Lee, Yena https://orcid.org/0000-0003-0629-9456
Mansur, Rodrigo B.
Brietzke, Elisa
Kapogiannis, Dimitrios https://orcid.org/0000-0003-2181-3118
Delgado-Peraza, Francheska https://orcid.org/0000-0003-0201-0248
Boutilier, Justin J.
Chan, Timothy C. Y. https://orcid.org/0000-0002-4128-1692
Carmona, Nicole E.
Rosenblat, Joshua D.
Lee, JungGoo
Maletic, Vladimir
Vinberg, Maj https://orcid.org/0000-0002-5982-1335
Suppes, Trisha
Goldstein, Benjamin I. https://orcid.org/0000-0003-0340-349X
Ravindran, Arun V.
Taylor, Valerie H.
Chawla, Sahil
Nogueras-Ortiz, Carlos
Cosgrove, Victoria E.
Kramer, Nicole E.
Ho, Roger https://orcid.org/0000-0001-9629-4493
Raison, Charles A. https://orcid.org/0000-0001-6687-0066
McIntyre, Roger S.
-
Funding
Funding for this research was provided by:
Stanley Medical Research Institute (13T-012)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (Z99 AG999999, ZIA AG000975)
Stanley Medical Research Institute - 13T-012
- License Information
-
More Information
Article History
Received: 5 August 2020
Revised: 25 January 2021
Accepted: 12 February 2021
First Online: 3 March 2021
Compliance with ethical standards
:
: RSM has received research grant support from the Stanley Medical Research Institute and the Canadian Institutes of Health Research/Global Alliance for Chronic Diseases/National Natural Science Foundation of China and speaker/consultation fees from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva within the past 36 months. EB has been supported by Faculty of Health Sciences, Queen’s University and received honoraria as speaker/member of advisory board from Daiichi-Sankyo not related to the content of this study. JDR has received research grant support from the University of Toronto, Canadian Cancer Society, Canadian Psychiatric Association, American Psychiatric Association, American Society of Psychopharmacology (New Investigator Award), University Health Network Centre for Mental Health, Joseph M. West Family Memorial Fund and Timeposters Fellowship and industry funding for speaker/consultation/research fees from Allergan, Lundbeck and COMPASS; and is the medical director of a private clinic providing off-label ketamine infusions for depression. BIG receives grant or research support from the Brain and Behavior Research Foundation (NARSAD), Brain Canada, the Canadian Institutes of Health Research, the Heart and Stroke Foundation, National Institute of Mental Health, the Ontario Ministry of Research and Innovation, and the Departments of Psychiatry of Sunnybrook Health Sciences Centre and the University of Toronto. MV has received consultancy fees from Lundbeck, Sunovion, and Janssen/Cilag within the last 3 years. All other authors declare no conflict of interest.
